Virtus Fund Advisers, LLC Veracyte, Inc. Transaction History
Virtus Fund Advisers, LLC
- $26.8 Million
- Q4 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 4,121 shares of VCYT stock, worth $169,414. This represents 0.61% of its overall portfolio holdings.
Number of Shares
4,121
Previous 4,798
14.11%
Holding current value
$169,414
Previous $163,000
-0.0%
% of portfolio
0.61%
Previous 0.81%
Shares
6 transactions
Others Institutions Holding VCYT
# of Institutions
336Shares Held
80MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$338 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$320 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$271 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$173 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$168 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.94B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...